Beatriz Cirauqui

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 578 citations

5-Year Analysis, Breast Oncology, Oncology +10

Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial

J. Guigay, Anne Aupérin, Jérôme Fayette et al. · The Lancet Oncology · 2021 · 214 citations

Gortec 2014-01 Tpextreme, Neoadjuvant Therapy, Medicine +11

A randomized phase II trial of platinum salts in basal-like breast cancer patients in the neoadjuvant setting. Results from the GEICAM/2006-03, multicenter study

Emilio Alba, José Ignacio Chacón, Aňa Lluch et al. · Breast Cancer Research and Treatment · 2012 · 143 citations · Full text

Neoadjuvant Setting, Oncology, Breast Oncology +10

Mutations in the tyrosine kinase domain of the EGFR gene associated with gefitinib response in non-small-cell lung cancer

Rafael Rosell, Yukito Ichinose, Miquel Tarón et al. · Lung Cancer · 2005 · 72 citations

Gefitinib Response, Medicine, Receptor Tyrosine Kinase +8

Effect of a diet and physical activity intervention on body weight and nutritional patterns in overweight and obese breast cancer survivors

Noémie Travier, Ana Fonseca‐Nunes, Casimiro Javierre et al. · Medical Oncology · 2013 · 64 citations

Obesity, Nutrition, Physical Activity +11